FDA Inspection
LVMH Fragrance BrandsLVMH Fragrance Brands – FDA Inspection, Sep 13, 2019
Record Details
This FDA Inspection record concerns LVMH Fragrance Brands, with an inspection on September 13, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Jamie L. Dion (Issuing Officer)
View Company Profile
ID · f8e96b4b-6938-492f-b76a-18ed0b7958ea
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1103533
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.188(b)(11)Identification of Persons Performing Significant Steps
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LVMH Fragrance Brands
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LVMH Fragrance Brands
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.